Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ: REGN · Real-Time Price · USD

793.53

-9.64 (-1.20%)

At close: Feb 17, 2026, 4:00 PM EST

783.91

-9.62 (-1.21%)

Pre-market: Feb 18, 2026, 8:05 AM EST

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	81,432	79,193	76,639	93,403	77,057	66,029
Market Cap Growth	10.11%	3.33%	-17.95%	21.21%	16.70%	29.49%
Enterprise Value	65,539	63,170	61,056	80,414	66,767	57,309
Last Close Price	793.53	771.87	708.40	873.45	717.51	628.04
PE Ratio	19.13	17.58	17.37	23.63	17.76	8.18
Forward PE	17.76	17.11	15.19	19.36	17.29	11.00
PS Ratio	5.79	5.52	5.40	7.12	6.33	4.11
PB Ratio	2.60	2.53	2.61	3.60	3.40	3.52
P/TBV Ratio	2.71	2.64	2.72	3.75	3.54	3.52
P/FCF Ratio	19.96	19.41	20.91	24.10	17.42	10.11
P/OCF Ratio	16.36	15.91	17.34	20.33	15.37	9.32
PEG Ratio	2.04	2.93	0.95	4.75	-	-
EV/Sales Ratio	4.57	4.40	4.30	6.13	5.49	3.57
EV/EBITDA Ratio	15.44	14.88	13.19	17.28	12.51	6.18
EV/EBIT Ratio	17.70	17.06	14.73	19.00	13.37	6.37
EV/FCF Ratio	16.06	15.48	16.66	20.75	15.09	8.78
Debt / Equity Ratio	0.10	0.10	0.10	0.11	0.12	0.14
Debt / EBITDA Ratio	0.69	0.69	0.63	0.60	0.52	0.29
Debt / FCF Ratio	0.73	0.73	0.80	0.72	0.63	0.41
Net Debt / Equity Ratio	-0.51	-0.51	-0.51	-0.52	-0.51	-0.52
Net Debt / EBITDA Ratio	-3.74	-3.74	-3.23	-2.89	-2.17	-1.06
Net Debt / FCF Ratio	-3.89	-3.89	-4.09	-3.47	-2.61	-1.51
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.76
Inventory Turnover	2.53	2.53	2.51	2.51	2.37	2.74
Quick Ratio	3.28	3.28	3.86	4.82	4.16	2.98
Current Ratio	4.13	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	5.91%	5.91%	7.31%	8.49%	11.42%	26.39%
Return on Invested Capital (ROIC)	12.54%	13.04%	18.58%	22.38%	26.65%	60.13%
Return on Capital Employed (ROCE)	10.20%	10.20%	12.30%	14.30%	19.20%	41.80%
Earnings Yield	5.53%	5.69%	5.76%	4.23%	5.63%	12.23%
FCF Yield	5.01%	5.15%	4.78%	4.15%	5.74%	9.89%
Dividend Yield	0.47%	0.46%	-	-	-	-
Payout Ratio	8.63%	8.22%	-	-	-	-
Buyback Yield / Dilution	5.65%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	6.12%	6.10%	-1.23%	-0.18%	-1.16%	2.52%

Updated Jan 30, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q